Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.
Identifieur interne : 004460 ( Ncbi/Merge ); précédent : 004459; suivant : 004461Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.
Auteurs : Sophie M. Bruinsma [Pays-Bas] ; Monique J. Roobol [Pays-Bas] ; Peter R. Carroll [États-Unis] ; Laurence Klotz [Canada] ; Tom Pickles [Canada] ; Caroline M. Moore [Royaume-Uni] ; Vincent J. Gnanapragasam [Royaume-Uni] ; Arnauld Villers [France] ; Antti Rannikko [Finlande] ; Riccardo Valdagni [Italie] ; Mark Frydenberg [Australie] ; Yoshiyuki Kakehi [Japon] ; Christopher P. Filson [États-Unis] ; Chris H. Bangma [Pays-Bas]Source :
- Nature reviews. Urology [ 1759-4820 ] ; 2017.
Abstract
Active surveillance (AS) is broadly described as a management option for men with low-risk prostate cancer, but semantic heterogeneity exists in both the literature and in guidelines. To address this issue, a panel of leading prostate cancer specialists in the field of AS participated in a consensus-forming project using a modified Delphi method to reach international consensus on definitions of terms related to this management option. An iterative three-round sequence of online questionnaires designed to address 61 individual items was completed by each panel member. Consensus was considered to be reached if ≥70% of the experts agreed on a definition. To facilitate a common understanding among all experts involved and resolve potential ambiguities, a face-to-face consensus meeting was held between Delphi survey rounds two and three. Convenience sampling was used to construct the panel of experts. In total, 12 experts from Australia, France, Finland, Italy, the Netherlands, Japan, the UK, Canada and the USA participated. By the end of the Delphi process, formal consensus was achieved for 100% (n = 61) of the terms and a glossary was then developed. Agreement between international experts has been reached on relevant terms and subsequent definitions regarding AS for patients with localized prostate cancer. This standard terminology could support multidisciplinary communication, reduce the extent of variations in clinical practice and optimize clinical decision making.
DOI: 10.1038/nrurol.2017.26
PubMed: 28290462
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000D16
- to stream PubMed, to step Curation: 000D13
- to stream PubMed, to step Checkpoint: 000D13
Links to Exploration step
pubmed:28290462Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.</title><author><name sortKey="Bruinsma, Sophie M" sort="Bruinsma, Sophie M" uniqKey="Bruinsma S" first="Sophie M" last="Bruinsma">Sophie M. Bruinsma</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam</wicri:regionArea><wicri:noRegion>3015 CN Rotterdam</wicri:noRegion></affiliation></author><author><name sortKey="Roobol, Monique J" sort="Roobol, Monique J" uniqKey="Roobol M" first="Monique J" last="Roobol">Monique J. Roobol</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam</wicri:regionArea><wicri:noRegion>3015 CN Rotterdam</wicri:noRegion></affiliation></author><author><name sortKey="Carroll, Peter R" sort="Carroll, Peter R" uniqKey="Carroll P" first="Peter R" last="Carroll">Peter R. Carroll</name><affiliation wicri:level="1"><nlm:affiliation>University of California, San Francisco, 550 16th Street, Department of Urology, 6th Floor, Mailbox Code 1695, San Francisco, California 94143, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of California, San Francisco, 550 16th Street, Department of Urology, 6th Floor, Mailbox Code 1695, San Francisco, California 94143</wicri:regionArea><wicri:noRegion>California 94143</wicri:noRegion></affiliation></author><author><name sortKey="Klotz, Laurence" sort="Klotz, Laurence" uniqKey="Klotz L" first="Laurence" last="Klotz">Laurence Klotz</name><affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, #MG 408, Toronto, Ontario M4N 3M5, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, #MG 408, Toronto, Ontario M4N 3M5</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Pickles, Tom" sort="Pickles, Tom" uniqKey="Pickles T" first="Tom" last="Pickles">Tom Pickles</name><affiliation wicri:level="1"><nlm:affiliation>University of British Columbia, Department of Radiotherapy &Developmental Radiotherapeutics, Radiation Oncology, BC Cancer Agency, 600 West 10th Avenue Vancouver, British Columbia, V6R 2T9, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of British Columbia, Department of Radiotherapy &Developmental Radiotherapeutics, Radiation Oncology, BC Cancer Agency, 600 West 10th Avenue Vancouver, British Columbia, V6R 2T9</wicri:regionArea><wicri:noRegion>V6R 2T9</wicri:noRegion></affiliation></author><author><name sortKey="Moore, Caroline M" sort="Moore, Caroline M" uniqKey="Moore C" first="Caroline M" last="Moore">Caroline M. Moore</name><affiliation wicri:level="1"><nlm:affiliation>University College London and University College London Hospitals Trust, 4th Floor, Rockefeller Building, 74 Huntley Street, London, WC1E 6AU, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University College London and University College London Hospitals Trust, 4th Floor, Rockefeller Building, 74 Huntley Street, London, WC1E 6AU</wicri:regionArea><wicri:noRegion>WC1E 6AU</wicri:noRegion></affiliation></author><author><name sortKey="Gnanapragasam, Vincent J" sort="Gnanapragasam, Vincent J" uniqKey="Gnanapragasam V" first="Vincent J" last="Gnanapragasam">Vincent J. Gnanapragasam</name><affiliation wicri:level="4"><nlm:affiliation>Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge CB2 0QQ</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Villers, Arnauld" sort="Villers, Arnauld" uniqKey="Villers A" first="Arnauld" last="Villers">Arnauld Villers</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Hôpital Huriez, Place de Verdun, Centre Hospitalier Regional Universitaire, 59037 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Urology, Hôpital Huriez, Place de Verdun, Centre Hospitalier Regional Universitaire, 59037 Lille</wicri:regionArea><wicri:noRegion>59037 Lille</wicri:noRegion><wicri:noRegion>59037 Lille</wicri:noRegion></affiliation></author><author><name sortKey="Rannikko, Antti" sort="Rannikko, Antti" uniqKey="Rannikko A" first="Antti" last="Rannikko">Antti Rannikko</name><affiliation wicri:level="1"><nlm:affiliation>Helsinki University and Helsinki University Hospital, Department of Urology, PL340, 00029 HUS, Helsinki, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Helsinki University and Helsinki University Hospital, Department of Urology, PL340, 00029 HUS, Helsinki</wicri:regionArea><wicri:noRegion>Helsinki</wicri:noRegion></affiliation></author><author><name sortKey="Valdagni, Riccardo" sort="Valdagni, Riccardo" uniqKey="Valdagni R" first="Riccardo" last="Valdagni">Riccardo Valdagni</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1 - 20133 Milano, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1 - 20133 Milano</wicri:regionArea><wicri:noRegion>Via G. Venezian 1 - 20133 Milano</wicri:noRegion></affiliation></author><author><name sortKey="Frydenberg, Mark" sort="Frydenberg, Mark" uniqKey="Frydenberg M" first="Mark" last="Frydenberg">Mark Frydenberg</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Monash Health; Department of Surgery, Faculty of Medicine, Monash University, 322 Glenferrie Road, Malvern, Melbourne 3144, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Urology, Monash Health; Department of Surgery, Faculty of Medicine, Monash University, 322 Glenferrie Road, Malvern, Melbourne 3144, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Kakehi, Yoshiyuki" sort="Kakehi, Yoshiyuki" uniqKey="Kakehi Y" first="Yoshiyuki" last="Kakehi">Yoshiyuki Kakehi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793</wicri:regionArea><wicri:noRegion>Kagawa 761-0793</wicri:noRegion></affiliation></author><author><name sortKey="Filson, Christopher P" sort="Filson, Christopher P" uniqKey="Filson C" first="Christopher P" last="Filson">Christopher P. Filson</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, Winship Cancer Center, Emory University School of Medicine, 1365 Clifton Road NE, Suite B1400, Atlanta, Georgia, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Urology, Winship Cancer Center, Emory University School of Medicine, 1365 Clifton Road NE, Suite B1400, Atlanta, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Bangma, Chris H" sort="Bangma, Chris H" uniqKey="Bangma C" first="Chris H" last="Bangma">Chris H. Bangma</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam</wicri:regionArea><wicri:noRegion>3015 CN Rotterdam</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28290462</idno><idno type="pmid">28290462</idno><idno type="doi">10.1038/nrurol.2017.26</idno><idno type="wicri:Area/PubMed/Corpus">000D16</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D16</idno><idno type="wicri:Area/PubMed/Curation">000D13</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D13</idno><idno type="wicri:Area/PubMed/Checkpoint">000D13</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D13</idno><idno type="wicri:Area/Ncbi/Merge">004460</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.</title><author><name sortKey="Bruinsma, Sophie M" sort="Bruinsma, Sophie M" uniqKey="Bruinsma S" first="Sophie M" last="Bruinsma">Sophie M. Bruinsma</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam</wicri:regionArea><wicri:noRegion>3015 CN Rotterdam</wicri:noRegion></affiliation></author><author><name sortKey="Roobol, Monique J" sort="Roobol, Monique J" uniqKey="Roobol M" first="Monique J" last="Roobol">Monique J. Roobol</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam</wicri:regionArea><wicri:noRegion>3015 CN Rotterdam</wicri:noRegion></affiliation></author><author><name sortKey="Carroll, Peter R" sort="Carroll, Peter R" uniqKey="Carroll P" first="Peter R" last="Carroll">Peter R. Carroll</name><affiliation wicri:level="1"><nlm:affiliation>University of California, San Francisco, 550 16th Street, Department of Urology, 6th Floor, Mailbox Code 1695, San Francisco, California 94143, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of California, San Francisco, 550 16th Street, Department of Urology, 6th Floor, Mailbox Code 1695, San Francisco, California 94143</wicri:regionArea><wicri:noRegion>California 94143</wicri:noRegion></affiliation></author><author><name sortKey="Klotz, Laurence" sort="Klotz, Laurence" uniqKey="Klotz L" first="Laurence" last="Klotz">Laurence Klotz</name><affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, #MG 408, Toronto, Ontario M4N 3M5, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, #MG 408, Toronto, Ontario M4N 3M5</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Pickles, Tom" sort="Pickles, Tom" uniqKey="Pickles T" first="Tom" last="Pickles">Tom Pickles</name><affiliation wicri:level="1"><nlm:affiliation>University of British Columbia, Department of Radiotherapy &Developmental Radiotherapeutics, Radiation Oncology, BC Cancer Agency, 600 West 10th Avenue Vancouver, British Columbia, V6R 2T9, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of British Columbia, Department of Radiotherapy &Developmental Radiotherapeutics, Radiation Oncology, BC Cancer Agency, 600 West 10th Avenue Vancouver, British Columbia, V6R 2T9</wicri:regionArea><wicri:noRegion>V6R 2T9</wicri:noRegion></affiliation></author><author><name sortKey="Moore, Caroline M" sort="Moore, Caroline M" uniqKey="Moore C" first="Caroline M" last="Moore">Caroline M. Moore</name><affiliation wicri:level="1"><nlm:affiliation>University College London and University College London Hospitals Trust, 4th Floor, Rockefeller Building, 74 Huntley Street, London, WC1E 6AU, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University College London and University College London Hospitals Trust, 4th Floor, Rockefeller Building, 74 Huntley Street, London, WC1E 6AU</wicri:regionArea><wicri:noRegion>WC1E 6AU</wicri:noRegion></affiliation></author><author><name sortKey="Gnanapragasam, Vincent J" sort="Gnanapragasam, Vincent J" uniqKey="Gnanapragasam V" first="Vincent J" last="Gnanapragasam">Vincent J. Gnanapragasam</name><affiliation wicri:level="4"><nlm:affiliation>Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge CB2 0QQ</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Villers, Arnauld" sort="Villers, Arnauld" uniqKey="Villers A" first="Arnauld" last="Villers">Arnauld Villers</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Hôpital Huriez, Place de Verdun, Centre Hospitalier Regional Universitaire, 59037 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Urology, Hôpital Huriez, Place de Verdun, Centre Hospitalier Regional Universitaire, 59037 Lille</wicri:regionArea><wicri:noRegion>59037 Lille</wicri:noRegion><wicri:noRegion>59037 Lille</wicri:noRegion></affiliation></author><author><name sortKey="Rannikko, Antti" sort="Rannikko, Antti" uniqKey="Rannikko A" first="Antti" last="Rannikko">Antti Rannikko</name><affiliation wicri:level="1"><nlm:affiliation>Helsinki University and Helsinki University Hospital, Department of Urology, PL340, 00029 HUS, Helsinki, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Helsinki University and Helsinki University Hospital, Department of Urology, PL340, 00029 HUS, Helsinki</wicri:regionArea><wicri:noRegion>Helsinki</wicri:noRegion></affiliation></author><author><name sortKey="Valdagni, Riccardo" sort="Valdagni, Riccardo" uniqKey="Valdagni R" first="Riccardo" last="Valdagni">Riccardo Valdagni</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1 - 20133 Milano, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1 - 20133 Milano</wicri:regionArea><wicri:noRegion>Via G. Venezian 1 - 20133 Milano</wicri:noRegion></affiliation></author><author><name sortKey="Frydenberg, Mark" sort="Frydenberg, Mark" uniqKey="Frydenberg M" first="Mark" last="Frydenberg">Mark Frydenberg</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Monash Health; Department of Surgery, Faculty of Medicine, Monash University, 322 Glenferrie Road, Malvern, Melbourne 3144, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Urology, Monash Health; Department of Surgery, Faculty of Medicine, Monash University, 322 Glenferrie Road, Malvern, Melbourne 3144, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Kakehi, Yoshiyuki" sort="Kakehi, Yoshiyuki" uniqKey="Kakehi Y" first="Yoshiyuki" last="Kakehi">Yoshiyuki Kakehi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793</wicri:regionArea><wicri:noRegion>Kagawa 761-0793</wicri:noRegion></affiliation></author><author><name sortKey="Filson, Christopher P" sort="Filson, Christopher P" uniqKey="Filson C" first="Christopher P" last="Filson">Christopher P. Filson</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, Winship Cancer Center, Emory University School of Medicine, 1365 Clifton Road NE, Suite B1400, Atlanta, Georgia, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Urology, Winship Cancer Center, Emory University School of Medicine, 1365 Clifton Road NE, Suite B1400, Atlanta, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Bangma, Chris H" sort="Bangma, Chris H" uniqKey="Bangma C" first="Chris H" last="Bangma">Chris H. Bangma</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam</wicri:regionArea><wicri:noRegion>3015 CN Rotterdam</wicri:noRegion></affiliation></author></analytic><series><title level="j">Nature reviews. Urology</title><idno type="eISSN">1759-4820</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Active surveillance (AS) is broadly described as a management option for men with low-risk prostate cancer, but semantic heterogeneity exists in both the literature and in guidelines. To address this issue, a panel of leading prostate cancer specialists in the field of AS participated in a consensus-forming project using a modified Delphi method to reach international consensus on definitions of terms related to this management option. An iterative three-round sequence of online questionnaires designed to address 61 individual items was completed by each panel member. Consensus was considered to be reached if ≥70% of the experts agreed on a definition. To facilitate a common understanding among all experts involved and resolve potential ambiguities, a face-to-face consensus meeting was held between Delphi survey rounds two and three. Convenience sampling was used to construct the panel of experts. In total, 12 experts from Australia, France, Finland, Italy, the Netherlands, Japan, the UK, Canada and the USA participated. By the end of the Delphi process, formal consensus was achieved for 100% (n = 61) of the terms and a glossary was then developed. Agreement between international experts has been reached on relevant terms and subsequent definitions regarding AS for patients with localized prostate cancer. This standard terminology could support multidisciplinary communication, reduce the extent of variations in clinical practice and optimize clinical decision making.</div></front></TEI><pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">28290462</PMID><DateCreated><Year>2017</Year><Month>03</Month><Day>14</Day></DateCreated><DateRevised><Year>2017</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-4820</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature reviews. Urology</Title><ISOAbbreviation>Nat Rev Urol</ISOAbbreviation></Journal><ArticleTitle>Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.</ArticleTitle><Pagination><MedlinePgn>312-322</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nrurol.2017.26</ELocationID><Abstract><AbstractText>Active surveillance (AS) is broadly described as a management option for men with low-risk prostate cancer, but semantic heterogeneity exists in both the literature and in guidelines. To address this issue, a panel of leading prostate cancer specialists in the field of AS participated in a consensus-forming project using a modified Delphi method to reach international consensus on definitions of terms related to this management option. An iterative three-round sequence of online questionnaires designed to address 61 individual items was completed by each panel member. Consensus was considered to be reached if ≥70% of the experts agreed on a definition. To facilitate a common understanding among all experts involved and resolve potential ambiguities, a face-to-face consensus meeting was held between Delphi survey rounds two and three. Convenience sampling was used to construct the panel of experts. In total, 12 experts from Australia, France, Finland, Italy, the Netherlands, Japan, the UK, Canada and the USA participated. By the end of the Delphi process, formal consensus was achieved for 100% (n = 61) of the terms and a glossary was then developed. Agreement between international experts has been reached on relevant terms and subsequent definitions regarding AS for patients with localized prostate cancer. This standard terminology could support multidisciplinary communication, reduce the extent of variations in clinical practice and optimize clinical decision making.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bruinsma</LastName><ForeName>Sophie M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roobol</LastName><ForeName>Monique J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>University of California, San Francisco, 550 16th Street, Department of Urology, 6th Floor, Mailbox Code 1695, San Francisco, California 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klotz</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, #MG 408, Toronto, Ontario M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickles</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of British Columbia, Department of Radiotherapy &Developmental Radiotherapeutics, Radiation Oncology, BC Cancer Agency, 600 West 10th Avenue Vancouver, British Columbia, V6R 2T9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Caroline M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>University College London and University College London Hospitals Trust, 4th Floor, Rockefeller Building, 74 Huntley Street, London, WC1E 6AU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gnanapragasam</LastName><ForeName>Vincent J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villers</LastName><ForeName>Arnauld</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, Hôpital Huriez, Place de Verdun, Centre Hospitalier Regional Universitaire, 59037 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rannikko</LastName><ForeName>Antti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Helsinki University and Helsinki University Hospital, Department of Urology, PL340, 00029 HUS, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdagni</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1 - 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frydenberg</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Monash Health; Department of Surgery, Faculty of Medicine, Monash University, 322 Glenferrie Road, Malvern, Melbourne 3144, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakehi</LastName><ForeName>Yoshiyuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filson</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Urology, Winship Cancer Center, Emory University School of Medicine, 1365 Clifton Road NE, Suite B1400, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangma</LastName><ForeName>Chris H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Urol</MedlineTA><NlmUniqueID>101500082</NlmUniqueID><ISSNLinking>1759-4812</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>BMC Med Res Methodol. 2005 Dec 01;5:37</RefSource><PMID Version="1">16321161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Nurs. 2015 Feb;24(3-4):344-52</RefSource><PMID Version="1">24813851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2012 Dec;62(6):976-83</RefSource><PMID Version="1">22698574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med Res Methodol. 2006 Jan 24;6:2</RefSource><PMID Version="1">16433905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2017 Apr;71(4):648-655</RefSource><PMID Version="1">27349615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2016 Mar;69(3):428-35</RefSource><PMID Version="1">26166626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Evid Rep Technol Assess (Full Rep). 2011 Dec;(204):1-341</RefSource><PMID Version="1">23126653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2014;2014:590638</RefSource><PMID Version="1">25215284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2013 May;111(5):753-60</RefSource><PMID Version="1">23464824</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Adv Nurs. 2003 Feb;41(4):376-82</RefSource><PMID Version="1">12581103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2015 Apr;67(4):627-36</RefSource><PMID Version="1">25511988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Health Drug Benefits. 2016 Feb;9(1):42-50</RefSource><PMID Version="1">27066195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2012 Feb;13(2):e77-82</RefSource><PMID Version="1">22300862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Adv Nurs. 2000 Oct;32(4):1008-15</RefSource><PMID Version="1">11095242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Urol. 2016 Mar;13(3):151-67</RefSource><PMID Version="1">26813955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can Urol Assoc J. 2015 May-Jun;9(5-6):171-8</RefSource><PMID Version="1">26225165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jun 26;9(6):e100227</RefSource><PMID Version="1">24968228</PMID></CommentsCorrections></CommentsCorrectionsList><InvestigatorList><Investigator ValidYN="Y"><LastName>Trock</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ehdaie</LastName><ForeName>Behfar</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carroll</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Filson</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Jeri</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morgan</LastName><ForeName>Todd</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klotz</LastName><ForeName>Laurence</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pickles</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hyndman</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>M Moore</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gnanapragasam</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Hemelrijck</LastName><ForeName>Mieke</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dasgupta</LastName><ForeName>Prokar</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bangma</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roobol</LastName><ForeName>Monique</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villers</LastName><ForeName>Arnauld</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rannikko</LastName><ForeName>Antti</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valdagni</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perry</LastName><ForeName>Antoinette</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hugosson</LastName><ForeName>Jonas</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rubio-Briones</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bjartell</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hefermehl</LastName><ForeName>Lukas</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lui Shiong</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frydenberg</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kakehi</LastName><ForeName>Yoshiyuki</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ha Chung</LastName><ForeName>Byung</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suk Lee</LastName><ForeName>Kwang</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Kwast</LastName><ForeName>Theo</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Obbink</LastName><ForeName>Henk</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Linden</LastName><ForeName>Wim</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hulsen</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Jonge</LastName><ForeName>Cees</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kattan</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xinge</LastName><ForeName>Ji</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muir</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lophatananon</LastName><ForeName>Artitaya</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fahey</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steyerberg</LastName><ForeName>Ewout</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nieboer</LastName><ForeName>Daan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liying</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guo</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milan</LastName><ForeName>Tanya</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benfante</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cowan</LastName><ForeName>Janet</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patil</LastName><ForeName>Dattatraya</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanford</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae-Kyung</ForeName><Initials>TK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mamedov</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>LaPointe</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crump</LastName><ForeName>Trafford</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hamoudi</LastName><ForeName>Rifat</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kimberly-Duffell</LastName><ForeName>Jenna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santaolalla</LastName><ForeName>Aida</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nieboer</LastName><ForeName>Daan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olivier</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Janetti</LastName><ForeName>Emanuele Bianchi</ForeName><Initials>EB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rancati</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahlgren</LastName><ForeName>Helén</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mascarós</LastName><ForeName>Juanma</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Löfgren</LastName><ForeName>Annica</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Kurt</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Han Lin</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hirama</LastName><ForeName>Hiromi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jenster</LastName><ForeName>Guido</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Auvinen</LastName><ForeName>Anssi</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bjartell</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haider</LastName><ForeName>Masoom</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Bochove</LastName><ForeName>Kees</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carter</LastName><ForeName>Ballentine</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirk-Burnnand</LastName><ForeName>Rachelle</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gledhill</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buzza</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruinsma</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28290462</ArticleId><ArticleId IdType="pii">nrurol.2017.26</ArticleId><ArticleId IdType="doi">10.1038/nrurol.2017.26</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Canada</li><li>Finlande</li><li>France</li><li>Italie</li><li>Japon</li><li>Pays-Bas</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Angleterre de l'Est</li><li>Géorgie (États-Unis)</li><li>Ontario</li></region><settlement><li>Cambridge</li><li>Toronto</li></settlement><orgName><li>Université de Cambridge</li><li>Université de Toronto</li></orgName></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Bruinsma, Sophie M" sort="Bruinsma, Sophie M" uniqKey="Bruinsma S" first="Sophie M" last="Bruinsma">Sophie M. Bruinsma</name></noRegion><name sortKey="Bangma, Chris H" sort="Bangma, Chris H" uniqKey="Bangma C" first="Chris H" last="Bangma">Chris H. Bangma</name><name sortKey="Roobol, Monique J" sort="Roobol, Monique J" uniqKey="Roobol M" first="Monique J" last="Roobol">Monique J. Roobol</name></country><country name="États-Unis"><noRegion><name sortKey="Carroll, Peter R" sort="Carroll, Peter R" uniqKey="Carroll P" first="Peter R" last="Carroll">Peter R. Carroll</name></noRegion><name sortKey="Filson, Christopher P" sort="Filson, Christopher P" uniqKey="Filson C" first="Christopher P" last="Filson">Christopher P. Filson</name></country><country name="Canada"><region name="Ontario"><name sortKey="Klotz, Laurence" sort="Klotz, Laurence" uniqKey="Klotz L" first="Laurence" last="Klotz">Laurence Klotz</name></region><name sortKey="Pickles, Tom" sort="Pickles, Tom" uniqKey="Pickles T" first="Tom" last="Pickles">Tom Pickles</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Moore, Caroline M" sort="Moore, Caroline M" uniqKey="Moore C" first="Caroline M" last="Moore">Caroline M. Moore</name></noRegion><name sortKey="Gnanapragasam, Vincent J" sort="Gnanapragasam, Vincent J" uniqKey="Gnanapragasam V" first="Vincent J" last="Gnanapragasam">Vincent J. Gnanapragasam</name></country><country name="France"><noRegion><name sortKey="Villers, Arnauld" sort="Villers, Arnauld" uniqKey="Villers A" first="Arnauld" last="Villers">Arnauld Villers</name></noRegion></country><country name="Finlande"><noRegion><name sortKey="Rannikko, Antti" sort="Rannikko, Antti" uniqKey="Rannikko A" first="Antti" last="Rannikko">Antti Rannikko</name></noRegion></country><country name="Italie"><noRegion><name sortKey="Valdagni, Riccardo" sort="Valdagni, Riccardo" uniqKey="Valdagni R" first="Riccardo" last="Valdagni">Riccardo Valdagni</name></noRegion></country><country name="Australie"><noRegion><name sortKey="Frydenberg, Mark" sort="Frydenberg, Mark" uniqKey="Frydenberg M" first="Mark" last="Frydenberg">Mark Frydenberg</name></noRegion></country><country name="Japon"><noRegion><name sortKey="Kakehi, Yoshiyuki" sort="Kakehi, Yoshiyuki" uniqKey="Kakehi Y" first="Yoshiyuki" last="Kakehi">Yoshiyuki Kakehi</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004460 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004460 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28290462
|texte= Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28290462" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |